Asset Details
Do you wish to reserve the book?
Potential Clinical Applications of Pro-Resolving Lipids Mediators from Docosahexaenoic Acid
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Potential Clinical Applications of Pro-Resolving Lipids Mediators from Docosahexaenoic Acid
Do you wish to request the book?
Potential Clinical Applications of Pro-Resolving Lipids Mediators from Docosahexaenoic Acid
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Potential Clinical Applications of Pro-Resolving Lipids Mediators from Docosahexaenoic Acid
2023
Overview
Docosahexaenoic acid (C22:6n-3, DHA) is the precursor of specialized pro-resolving lipid mediators (SPMs), such as resolvin, protectin, and maresin families which have been considered therapeutic bioactive compounds for human health. Growing evidence indicates that DHA and SPMs are beneficial strategies in the amelioration, regulation, and duration of inflammatory processes through different biological actions. The present review discusses the reported therapeutic benefits of SPMs on various diseases and their potential clinical applications.
